H2020FP7HORIZON
Universitair Ziekenhuis Antwerpen
- Country
- BEBelgium
- Defence projects
- 0
- Projects, all programmes
- 36
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 22,461,565
- Active
- 2010 to 2025
Projects
36 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| ARREST BLINDNESSAdvanced Regenerative and REStorative Therapies to combat corneal BLINDNESS | H2020 | 2016 | Participant | EUR 738,065 |
| H2020MM04DC-based immunotherapy to treat Malignant Mesothelioma | H2020 | 2016 | Participant | EUR 668,875 |
| ND4IDNew Diagnostics for Infectious Diseases: “ND4ID” | H2020 | 2016 | Partner | EUR 0 |
| IABC PROGRAMMEiABC Programme | FP7 | 2015 | Participant | EUR 1,095,505 |
| DISCHARGEDiagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies | FP7 | 2014 | Participant | Not stated |
| HEPAVACCancer Vaccine development for Hepatocellular Carcinoma | FP7 | 2013 | Participant | EUR 115,850 |
| RESOLVEA systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol | FP7 | 2013 | Participant | EUR 591,050 |
| CULPRIT-SHOCKMultivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock | FP7 | 2013 | Participant | EUR 20,000 |
| OPTIMEXOptimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure | FP7 | 2013 | Participant | EUR 353,876 |
| CENTER-TBICollaborative European NeuroTrauma Effectiveness Research in TBI | FP7 | 2013 | Coordinator | EUR 11,728,072 |
| MERCURICA Phase Ia/b study of MEK1/2 inhibitor PD-0325901 or MEK-162 with cMET inhibitor PF-02341066 in RASMT and RASWT (with aberrant c-MET) Colorectal Cancer Patients. | FP7 | 2013 | Participant | EUR 346,183 |
| MyasterixClinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis | FP7 | 2013 | Participant | EUR 440,000 |
| BIP-UPYBioactive Implantable Polymers based on UreidoPyrimidinone | FP7 | 2013 | Participant | EUR 174,548 |
| QUIC-CONCEPTQUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy | FP7 | 2011 | Participant | EUR 445,000 |
| THE HIP TRIALManagement of Hypotension In the Preterm Extremely Low Gestational Age Newborn | FP7 | 2010 | Participant | EUR 60,000 |
| TRUSTTraining Urology Scientists to develop Treatments | FP7 | 2010 | Participant | EUR 445,989 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.